Clinical use of OCTA could represent paradigm shift

OCT angiography may represent a shifting paradigm, overtaking the use of fluorescein angiography in the clinic, according to a presenter at the virtual OSN New York Retina meeting.
“The technology will become even more powerful as the speed of OCT increases,” David Huang, MD, PhD, said.
Since its introduction into clinical environments in 2014, OCTA iterations now include spectral domain and swept source devices, with axial scan repetition rates greater than 100 kHz for some devices. Historically, on average, the speed of commercial OCT platforms doubles every 2 years, Huang said.

Full Story →